These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 10536005)

  • 41. Targeting of high-capacity adenoviral vectors.
    Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
    Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.
    Parks RJ; Bramson JL; Wan Y; Addison CL; Graham FL
    J Virol; 1999 Oct; 73(10):8027-34. PubMed ID: 10482551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expanded-capacity adenoviral vectors--the helper-dependent vectors.
    Morsy MA; Caskey CT
    Mol Med Today; 1999 Jan; 5(1):18-24. PubMed ID: 10088128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors.
    Schiedner G; Hertel S; Johnston M; Dries V; van Rooijen N; Kochanek S
    Mol Ther; 2003 Jan; 7(1):35-43. PubMed ID: 12573616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.
    Jooss K; Yang Y; Wilson JM
    Hum Gene Ther; 1996 Aug; 7(13):1555-66. PubMed ID: 8864756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced inflammatory reactions to the inoculation of helper-dependent adenoviral vectors in traumatically injured rat brain.
    Zou L; Yotnda P; Zhao T; Yuan X; Long Y; Zhou H; Yang K
    J Cereb Blood Flow Metab; 2002 Aug; 22(8):959-70. PubMed ID: 12172381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of promoters and enhancers on expression, transgene DNA persistence, and hepatotoxicity after adenoviral gene transfer of human apolipoprotein A-I.
    Van Linthout S; Collen D; De Geest B
    Hum Gene Ther; 2002 May; 13(7):829-40. PubMed ID: 11975849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.
    Raper SE; Haskal ZJ; Ye X; Pugh C; Furth EE; Gao GP; Wilson JM
    Hum Gene Ther; 1998 Mar; 9(5):671-9. PubMed ID: 9551615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenoviral vector immunity: its implications and circumvention strategies.
    Ahi YS; Bangari DS; Mittal SK
    Curr Gene Ther; 2011 Aug; 11(4):307-20. PubMed ID: 21453277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor.
    Oka K; Pastore L; Kim IH; Merched A; Nomura S; Lee HJ; Merched-Sauvage M; Arden-Riley C; Lee B; Finegold M; Beaudet A; Chan L
    Circulation; 2001 Mar; 103(9):1274-81. PubMed ID: 11238273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.
    Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA
    Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
    Kuzmin AI; Galenko O; Eisensmith RC
    Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.
    Sung RS; Qin L; Bromberg JS
    Mol Ther; 2001 May; 3(5 Pt 1):757-67. PubMed ID: 11356080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circumventing the immune response to adenovirus-mediated gene therapy.
    Kass-Eisler A; Leinwand L; Gall J; Bloom B; Falck-Pedersen E
    Gene Ther; 1996 Feb; 3(2):154-62. PubMed ID: 8867863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transient immunosuppression with deoxyspergualin improves longevity of transgene expression and ability to readminister adenoviral vector to the mouse lung.
    Kaplan JM; Smith AE
    Hum Gene Ther; 1997 Jun; 8(9):1095-104. PubMed ID: 9189767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells.
    Dorigo O; Gil JS; Gallaher SD; Tan BT; Castro MG; Lowenstein PR; Calos MP; Berk AJ
    J Virol; 2004 Jun; 78(12):6556-66. PubMed ID: 15163748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenoviral vectors for liver-directed gene therapy.
    Connelly S
    Curr Opin Mol Ther; 1999 Oct; 1(5):565-72. PubMed ID: 11249663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.
    Muruve DA; Cotter MJ; Zaiss AK; White LR; Liu Q; Chan T; Clark SA; Ross PJ; Meulenbroek RA; Maelandsmo GM; Parks RJ
    J Virol; 2004 Jun; 78(11):5966-72. PubMed ID: 15140994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adenovirus-mediated gene transfer into tumors: evaluation of direct readministration of an adenoviral vector into subcutaneous tumors of immunocompetent mice.
    Nagao S; Kuriyama S; Okuda H; Tominaga K; Nakatani T; Tsujinoue H; Yoshiji H; Fukui H
    Int J Oncol; 2001 Jan; 18(1):57-65. PubMed ID: 11115539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.